US Stock MarketDetailed Quotes

OLMA Olema Pharmaceuticals

Watchlist
  • 11.320
  • +0.120+1.07%
Close Mar 28 16:00 ET
  • 11.090
  • -0.230-2.03%
Post 19:29 ET
632.95MMarket Cap-5289P/E (TTM)

Olema Pharmaceuticals Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
(Q2)Jun 30, 2022
(Q1)Mar 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-1.89%104.96M
11.75%30.42M
0.52%23.34M
-35.12%21.6M
27.30%29.6M
49.65%106.99M
25.10%27.22M
30.74%23.22M
101.51%33.29M
50.51%23.25M
Selling and administrative expenses
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
21.20%24.71M
-2.54%5.64M
6.80%5.6M
35.28%6.24M
52.27%7.25M
-General and administrative expense
-23.84%18.82M
-19.36%4.54M
-30.49%3.89M
-42.11%3.61M
-6.47%6.78M
21.20%24.71M
-2.54%5.64M
6.80%5.6M
35.28%6.24M
52.27%7.25M
Research and development costs
4.70%86.14M
19.87%25.87M
10.36%19.45M
-33.51%17.99M
42.58%22.83M
61.01%82.27M
35.11%21.58M
40.76%17.63M
127.15%27.05M
49.73%16.01M
Operating profit
1.89%-104.96M
-11.75%-30.42M
-0.52%-23.34M
35.12%-21.6M
-27.30%-29.6M
-49.65%-106.99M
-25.10%-27.22M
-30.74%-23.22M
-101.51%-33.29M
-50.51%-23.25M
Net non-operating interest income expense
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
404.07%2.23M
792.66%973K
492.38%622K
254.70%415K
96.40%218K
Non-operating interest income
273.65%8.33M
264.95%3.55M
208.52%1.92M
273.49%1.55M
498.62%1.31M
404.07%2.23M
792.66%973K
492.38%622K
254.70%415K
96.40%218K
Other net income (expense)
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
42.55%-27K
570.00%67K
-114.29%-120K
2,100.00%20K
6K
Other non- operating income (expenses)
29.63%-19K
38.81%93K
34.17%-79K
-320.00%-44K
83.33%11K
42.55%-27K
570.00%67K
-114.29%-120K
2,100.00%20K
--6K
Income before tax
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
Income tax
Net income
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
Net income continuous Operations
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
Minority interest income
Net income attributable to the parent company
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
7.76%-96.66M
-2.27%-26.77M
5.36%-21.5M
38.84%-20.1M
-22.82%-28.29M
-47.39%-104.79M
-20.99%-26.18M
-28.27%-22.72M
-100.28%-32.86M
-50.14%-23.03M
Basic earnings per share
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
-45.56%-2.62
-20.37%-0.65
-26.67%-0.57
-95.24%-0.82
-48.72%-0.58
Diluted earnings per share
18.32%-2.14
26.15%-0.48
15.79%-0.48
40.24%-0.49
-20.69%-0.7
-45.56%-2.62
-20.37%-0.65
-26.67%-0.57
-95.24%-0.82
-48.72%-0.58
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022(Q2)Jun 30, 2022(Q1)Mar 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -1.89%104.96M11.75%30.42M0.52%23.34M-35.12%21.6M27.30%29.6M49.65%106.99M25.10%27.22M30.74%23.22M101.51%33.29M50.51%23.25M
Selling and administrative expenses -23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M21.20%24.71M-2.54%5.64M6.80%5.6M35.28%6.24M52.27%7.25M
-General and administrative expense -23.84%18.82M-19.36%4.54M-30.49%3.89M-42.11%3.61M-6.47%6.78M21.20%24.71M-2.54%5.64M6.80%5.6M35.28%6.24M52.27%7.25M
Research and development costs 4.70%86.14M19.87%25.87M10.36%19.45M-33.51%17.99M42.58%22.83M61.01%82.27M35.11%21.58M40.76%17.63M127.15%27.05M49.73%16.01M
Operating profit 1.89%-104.96M-11.75%-30.42M-0.52%-23.34M35.12%-21.6M-27.30%-29.6M-49.65%-106.99M-25.10%-27.22M-30.74%-23.22M-101.51%-33.29M-50.51%-23.25M
Net non-operating interest income expense 273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M404.07%2.23M792.66%973K492.38%622K254.70%415K96.40%218K
Non-operating interest income 273.65%8.33M264.95%3.55M208.52%1.92M273.49%1.55M498.62%1.31M404.07%2.23M792.66%973K492.38%622K254.70%415K96.40%218K
Other net income (expense) 29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K42.55%-27K570.00%67K-114.29%-120K2,100.00%20K6K
Other non- operating income (expenses) 29.63%-19K38.81%93K34.17%-79K-320.00%-44K83.33%11K42.55%-27K570.00%67K-114.29%-120K2,100.00%20K--6K
Income before tax 7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M-50.14%-23.03M
Income tax
Net income 7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M-50.14%-23.03M
Net income continuous Operations 7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M-50.14%-23.03M
Minority interest income
Net income attributable to the parent company 7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M-50.14%-23.03M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 7.76%-96.66M-2.27%-26.77M5.36%-21.5M38.84%-20.1M-22.82%-28.29M-47.39%-104.79M-20.99%-26.18M-28.27%-22.72M-100.28%-32.86M-50.14%-23.03M
Basic earnings per share 18.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7-45.56%-2.62-20.37%-0.65-26.67%-0.57-95.24%-0.82-48.72%-0.58
Diluted earnings per share 18.32%-2.1426.15%-0.4815.79%-0.4840.24%-0.49-20.69%-0.7-45.56%-2.62-20.37%-0.65-26.67%-0.57-95.24%-0.82-48.72%-0.58
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------Unqualified Opinion--------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg